title: Thymic tumours: an update.
abstract: Thymic malignancies are relatively uncommon tumours that display significant clinical, pathological, and molecular heterogeneity. Their management requires a multidisciplinary approach; because of their rarity, current indications are based on data from smaller, mostly institutional, series or retrospective analyses and controversies still exist. This article focuses on the principles of treatment of thymic malignancies. In the future, collaboration between many different institutions will open the opportunity to achieve a better understanding and management of the disease.
authors.affiliation: Gustave Roussy, Department of Cancer Medicine, Villejuif, France; Oncologic Venetian Institute, Department of Second Medical Oncology, Padua, Italy.
authors.forename: Valentina
authors.initials: V
authors.lastname: Polo
authors.forename: Nicolas
authors.initials: N
authors.lastname: Girard
authors.forename: Benjamin
authors.initials: B
authors.lastname: Besse
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000628:therapy; D006801:Humans; D020360:Neoadjuvant Therapy; D009367:Neoplasm Staging; D011879:Radiotherapy Dosage; D013945:Thymoma / Q000628:therapy; D013953:Thymus Neoplasms / Q000145:classification / Q000628:therapy*
chemical_list: D000970:Antineoplastic Agents